Mink Brook Asset Management LLC Ocuphire Pharma, Inc. Transaction History
Mink Brook Asset Management LLC
- $148 Billion
- Q3 2025
A detailed history of Mink Brook Asset Management LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Mink Brook Asset Management LLC holds 1,237,947 shares of OCUP stock, worth $1.21 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
1,237,947
Previous 1,197,616
3.37%
Holding current value
$1.21 Million
Previous $1.13 Billion
81.04%
% of portfolio
1.38%
Previous 0.98%
Shares
3 transactions
Others Institutions Holding OCUP
# of Institutions
53Shares Held
19.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.01% of portfolio
-
Bios Capital Management, LP Fort Worth, TX3.68MShares$3.61 Million7.42% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.35MShares$3.28 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$1.32 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA1.1MShares$1.08 Million0.18% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...